1. Home
  2. IDN vs LCTX Comparison

IDN vs LCTX Comparison

Compare IDN & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDN
  • LCTX
  • Stock Information
  • Founded
  • IDN 1994
  • LCTX 1990
  • Country
  • IDN United States
  • LCTX United States
  • Employees
  • IDN N/A
  • LCTX N/A
  • Industry
  • IDN Computer Software: Prepackaged Software
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IDN Technology
  • LCTX Health Care
  • Exchange
  • IDN Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • IDN 120.5M
  • LCTX 107.3M
  • IPO Year
  • IDN 1999
  • LCTX N/A
  • Fundamental
  • Price
  • IDN $5.38
  • LCTX $0.90
  • Analyst Decision
  • IDN Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • IDN 3
  • LCTX 5
  • Target Price
  • IDN $5.83
  • LCTX $4.20
  • AVG Volume (30 Days)
  • IDN 583.3K
  • LCTX 2.3M
  • Earning Date
  • IDN 08-07-2025
  • LCTX 08-07-2025
  • Dividend Yield
  • IDN N/A
  • LCTX N/A
  • EPS Growth
  • IDN N/A
  • LCTX N/A
  • EPS
  • IDN N/A
  • LCTX N/A
  • Revenue
  • IDN $20,211,000.00
  • LCTX $9,557,000.00
  • Revenue This Year
  • IDN $9.35
  • LCTX N/A
  • Revenue Next Year
  • IDN $13.05
  • LCTX $232.66
  • P/E Ratio
  • IDN N/A
  • LCTX N/A
  • Revenue Growth
  • IDN 4.55
  • LCTX 19.42
  • 52 Week Low
  • IDN $1.92
  • LCTX $0.37
  • 52 Week High
  • IDN $6.49
  • LCTX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • IDN 60.65
  • LCTX 74.23
  • Support Level
  • IDN $5.08
  • LCTX $0.67
  • Resistance Level
  • IDN $5.63
  • LCTX $0.83
  • Average True Range (ATR)
  • IDN 0.45
  • LCTX 0.06
  • MACD
  • IDN -0.11
  • LCTX 0.02
  • Stochastic Oscillator
  • IDN 21.28
  • LCTX 84.94

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: